IX vs V
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ORIX Corporation presents a stark contrast between strong valuation and weak fundamental health, highlighted by a critical Piotroski F-Score of 2/9. While the stock is significantly undervalued relative to its Graham Number ($39.02) and Intrinsic Value ($76.99), the low health score suggests deteriorating operational efficiency or financial stability. Strong earnings growth (36.6% YoY) and an exceptionally low forward P/E of 2.77 provide a bullish growth narrative, but these are offset by a bearish technical trend score and poor insider sentiment.
V shows bullish fundamentals based on deterministic rules. Financial strength is strong (F-Score 6/9). Key strengths include strong valuation and growth metrics.
Compare Another Pair
Related Comparisons
IX vs V: Head-to-Head Comparison
This page compares ORIX Corporation (IX) and Visa Inc. (V) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.